BCAR4 and breast carcinoma: The presence or absence of postoperative recurrence and time to postoperative recurrence of HCC was independently associated with ΔCt value of CDT1 (HR = 0.47, 95% CI 0.302–0.698, p = 0.0001), ΔCt value of breast cancer anti-estrogen resistance 4 (BCAR4) (HR = 0.396, 95% CI 0.220–0.734, p = 0.0028), and ΔCt value of Charcot-Marie-Tooth disease type 1A duplicated region transcript 15 pseudogene 2 (CDRT15P2) (HR = 4.454, 95% CI 1.619–13.026, p = 0.0035) (Table 3).